Related Experiment Videos
Nicotinic acid-induced fulminant hepatic failure.
1Department of Family Practice, University of Illinois College of Medicine at Peoria 61656.
Journal of Clinical Gastroenterology
|October 1, 1987
Summary
Nicotinic acid, used for high cholesterol, can cause severe liver injury. This case highlights the importance of monitoring for hepatotoxicity during treatment with nicotinic acid.
Area of Science:
- Hepatology
- Clinical Pharmacology
Background:
- Hypercholesterolemia is a common condition requiring treatment.
- Nicotinic acid (niacin) is a lipid-lowering agent.
- Hepatotoxicity is a known, though uncommon, side effect of nicotinic acid.
Observation:
- A 46-year-old man developed liver injury after starting 3g daily nicotinic acid for hypercholesterolemia.
- After a temporary cessation and re-initiation of therapy, the patient experienced fulminant hepatic failure.
- Symptoms resolved rapidly upon discontinuation of nicotinic acid.
Findings:
- The case suggests a direct causal link between nicotinic acid and drug-induced liver injury (DILI).
- The rapid onset and severity of hepatic failure were notable.
- This highlights the potential for significant hepatotoxicity even with short-term use.
Implications:
- Physicians and patients should be vigilant for signs of liver damage when using nicotinic acid.
- Increased use of nicotinic acid for cholesterol management necessitates heightened awareness of its hepatotoxic potential.
- Prompt recognition and cessation of the drug are crucial for managing nicotinic acid-induced liver injury.